Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company engages in the manufacture, marketing, and distribution of pharmaceutical and allied healthcare products in the nutraceuticals and herbal segments .
Plethico Pharmaceuticals Ltd., is a listed public company incorporated on 04 December, 1991. It is classified as a public limited company and is located in , Madhya Pradesh. It's authorized share capital is INR 60.00 cr and the total paid-up capital is INR 34.07 cr.
Read more
** All rupee values in INR crores.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Additional Director | Jignesh Jitendra Panchal | 07321142 | 10 years |
| Managing Director | Shashikant Patel | 00199120 | 35 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Allahabad Bank
No. of Loans: 3
Total Amount : 245.0 cr
Bank of India
No. of Loans: 1
Total Amount : 220.0 cr
Export-Import Bank of India
No. of Loans: 2
Total Amount : 85.0 cr
IDBI Bank Limited
No. of Loans: 3
Total Amount : 74.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 52.5 cr
Bank of Baroda
No. of Loans: 1
Total Amount : 47.5 cr
Punjab National Bank
No. of Loans: 1
Total Amount : 30.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| PLEARC LIMITED |
Strike Off
|
1.0 Cr | 1 | Madhya Pradesh |
| ATK LOGISTICS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| PINNACE AGRO EXIM & SERVICES PRIVATE LIMITED |
Active
|
50.0 L | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Natrol Global Fz LLC | United Arab Emirates | - | - |
| Natrol Products Inc | United States | - | - |
| Medical Research | United States | - | - |
| Natrol Direct Inc | United States | - | - |
| Prolab Nutrition Inc | United States | - | - |
| Plethico Global Holding BV | Netherlands | - | - |
| Plethico International Limited | United Arab Emirates | - | - |
| Natrol (UK) Ltd. | United Kingdom | - | - |
| Plethico US Holdings KFT | Hungary | - | - |
| Natrol Inc. | United States | - | - |
Read more
The incorporation date of PLETHICO PHARMACEUTICALS LTD. is 04 December, 1991
The authorized share capital of PLETHICO PHARMACEUTICALS LTD. is INR ₹ 60.0 Cr.
The paid-up capital of PLETHICO PHARMACEUTICALS LTD. is INR ₹ 34.1 Cr.
The registered address of PLETHICO PHARMACEUTICALS LTD. is A.B. ROAD, MANGLIA, INDORE, Madhya Pradesh, India, 453771 - 453771
The CIN number of PLETHICO PHARMACEUTICALS LTD. is L24232MP1991PLC006801.